|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
102,230,000 |
Market
Cap: |
10.87(M) |
Last
Volume: |
10,264,973 |
Avg
Vol: |
10,236,721 |
52
Week Range: |
$0.1063 - $1.64 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Seelos Therapeutics is a clinical-stage biopharmaceutical company focused on the development of products that address unmet needs in Central Nervous System disorders and other disorders. Co.'s primary programs are SLS-002 for the potential treatment of Acute Suicidal Ideation and Behavior in patients with Major Depressive Disorder and SLS-005 for the potential treatment of Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia. Co. is also developing several preclinical programs, including SLS-004, SLS-006, and SLS-007 for the potential treatment of Parkinson's Disease, SLS-010 in narcolepsy and related disorders, and SLS-012, an injectable therapy for post-operative pain management.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
158,757 |
158,757 |
209,757 |
Total Buy Value |
$0 |
$200,222 |
$200,222 |
$230,976 |
Total People Bought |
0 |
2 |
2 |
4 |
Total Buy Transactions |
0 |
2 |
2 |
4 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
May Jacob |
owns over 5% of securities |
|
2008-11-20 |
4 |
B |
$0.06 |
$1,287 |
D/D |
20,751 |
8,295,650 |
2.36 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-11-19 |
4 |
B |
$0.06 |
$7,893 |
D/D |
121,459 |
9,147,066 |
2.44 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-11-18 |
4 |
B |
$0.07 |
$10,288 |
D/D |
149,100 |
9,087,066 |
2.44 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-11-14 |
4 |
B |
$0.09 |
$9,200 |
D/D |
100,000 |
8,937,966 |
2.44 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-10-28 |
4 |
B |
$0.13 |
$875 |
D/D |
7,000 |
8,837,966 |
2.36 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-10-27 |
4 |
B |
$0.12 |
$25,826 |
D/D |
194,116 |
8,830,966 |
2.44 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-10-14 |
4 |
B |
$0.13 |
$7,334 |
D/D |
57,300 |
8,786,850 |
2.44 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-10-09 |
4 |
B |
$0.13 |
$2,250 |
D/D |
18,000 |
8,729,550 |
2.36 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-10-08 |
4 |
B |
$0.12 |
$9,240 |
D/D |
77,000 |
8,711,550 |
2.44 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-10-07 |
4 |
B |
$0.13 |
$17,018 |
D/D |
134,000 |
8,634,550 |
2.44 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-10-03 |
4 |
B |
$0.14 |
$14,000 |
D/D |
100,000 |
8,500,550 |
2.44 |
- |
|
Westgate Mark |
Vice President and CFO |
|
2008-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
729,318 |
|
- |
|
Pandya Hemanshu |
Vice President and COO |
|
2008-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
725,000 |
|
- |
|
May Jacob |
owns over 5% of securities |
|
2008-10-02 |
4 |
B |
$0.14 |
$3,475 |
D/D |
25,000 |
8,040,600 |
2.36 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-10-01 |
4 |
B |
$0.12 |
$1,500 |
D/D |
12,299 |
8,015,600 |
2.36 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-09-30 |
4 |
B |
$0.12 |
$13,420 |
D/D |
110,000 |
8,003,301 |
2.44 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-09-26 |
4 |
B |
$0.14 |
$846 |
D/D |
6,000 |
7,893,301 |
2.36 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-09-25 |
4 |
B |
$0.15 |
$906,753 |
D/D |
1,628,946 |
7,887,301 |
2.44 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-09-19 |
4 |
B |
$0.16 |
$24,000 |
D/D |
150,000 |
7,817,056 |
2.44 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-09-17 |
4 |
B |
$0.16 |
$105,150 |
D/D |
200,000 |
7,667,056 |
2.44 |
- |
|
Tierney David S |
Director |
|
2008-09-15 |
4 |
A |
$0.13 |
$1,477 |
D/D |
11,364 |
225,116 |
|
- |
|
Oppenheim Leonard A |
Director |
|
2008-09-15 |
4 |
A |
$0.13 |
$1,477 |
D/D |
11,364 |
320,019 |
|
- |
|
Emil Arthur D |
Director |
|
2008-09-15 |
4 |
A |
$0.13 |
$1,477 |
D/D |
11,364 |
280,747 |
|
- |
|
Berman Richard J |
Director |
|
2008-09-15 |
4 |
A |
$0.13 |
$1,724 |
D/D |
13,258 |
286,873 |
|
- |
|
Clark John Smith Ii |
10% Owner |
|
2008-08-27 |
4 |
S |
$0.25 |
$1,608,579 |
I/I |
(6,363,050) |
3,666,237 |
|
- |
|
395 Records found
|
|
Page 9 of 16 |
|
|